The latest lawsuit to go to trial in the Philadelphia Country Court of Common Pleas involving claims that the antipsychotic drug Risperdal caused an adolescent boy to grow disfiguring female breasts was axed mid-trial by the judge overseeing the case because the judge did not support the expert witness’ diagnosis of gynecomastia based solely on photographs. The family of the boy vowed to appeal. The lawsuit is one of more than 5,700 claims in a mass tort program in Philadelphia County alleging Risperdal makers Johnson & Johnson and its subsidiary Janssen Pharmaceuticals withheld data showing that Risperdal use in adolescent boys ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.